German health care group Fresenius plans to buy APP Pharmaceuticals in a $3.7 billion deal to expand into the North American intravenous generic drugs market.
Almost everywhere they looked during the week, investors saw red ink flowing. But CNBC guests worked hard to find bright spots in the murk.
To give investors an edge, CNBC asked the market experts for their best stock picks now.
Shares of many health-care companies have been hit hard this year. But Schwab's Paul Alan Davis says there are some promising opportunities.
"Health care" is two words -- and the health care sector is increasingly being viewed as two very different sectors: pharmaceuticals and managed care, which are in trouble; and medical devices and services, which are not. Paul Alan Davis of Charles Schwab Investment Management offered advice for playing the sector(s).
Embargoes imposed by scientific groups and medical journals will once again be put to the test over the next couple of months.
Goldman Sachs analysts say stock investors should look to larger cap and defensive sectors as a way to play the uncertainty of presidential primary season. While they say the major party nominees should become clear by "Super Duper Tuesday," there is greater electoral and policy uncertainty in this Presidential race because there are no incumbents running.
What's the difference between a best of breed medical stock and one that's worst of breed? Let Cramer explain it to you.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.
Today Cramer talks drilling stocks, MasterCard, Sprint and many, many more...